313TE targets IL-13Rα2-positive tumors in preclinical testing
A preclinical study reports that the IL-13E13Y-based T-cell engager 313TE linked IL-13Rα2-positive tumor cells to T cells, promoting receptor-dependent killing ...
A preclinical study reports that the IL-13E13Y-based T-cell engager 313TE linked IL-13Rα2-positive tumor cells to T cells, promoting receptor-dependent killing ...
Kansai Medical University Hospital gave the first worldwide dose of investigational CD25-directed antibody drug conjugate DS1025 in a global Phase ...
MSIPep combines immunopeptidomics, transcriptomics and deep learning to identify and computationally prioritize candidate tumor peptides in leukemia and solid-tumor datasets.
A 2026 narrative review finds that most myeloid-directed cancer programs show target activity without proving immune conversion and proposes a ...
Eleven studies using machine learning, single-cell profiling, imaging, liquid biopsy and clinical data identify candidate cancer biomarkers, but retrospective designs ...
A 2026 collection of five reviews and one small tissue-expression study shows that autophagy can restrain or support solid tumors ...
A Roche-led benchmark found that the 10X Genomics GEM-X Flex assay with chop-fix processing improves single-cell RNA profiling of frozen ...
A new review in Holistic Integrative Oncology charts the rapid rise of antibody–drug conjugates in solid tumors while detailing the ...
St. Jude scientists found that deleting the gene ZMYND8 relieves CD8-positive T-cell exhaustion and synergizes with immunotherapy to improve anti-tumor ...
A retrospective cohort study of 166 people living with HIV finds that hematologic malignancies strike younger patients, track with high ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine